Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5‐Year Data From the Phase 3 Long‐Term Odanacatib Fracture Trial (LOFT) and its Extension-Reference-Cited by-同舟云学术

Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5‐Year Data From the Phase 3 Long‐Term Odanacatib Fracture Trial (LOFT) and its Extension

Published:2020-05-05 Issue:7 Volume:35 Page:1289-1299
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Recker Robert¹,Dempster David²^ORCID,Langdahl Bente³^ORCID,Giezek Hilde⁴,Clark Seth⁵,Ellis Graham⁶,Villiers Tobias⁷,Valter Ivo⁸,Zerbini Cristiano AF⁹,Cohn Dosinda¹⁰,Santora Arthur¹¹,Duong Le T¹²

Affiliation:

1. Osteoporosis Research Center, School of MedicineCreighton University Omaha NE USA

2. Regional Bone Center, Helen Hayes HospitalWest Haverstraw and Columbia University New York NY USA

3. Department of Endocrinology and Internal MedicineAarhus University Hospital Aarhus Denmark

4. Biostatistics, MSD Europe Inc. Brussels Belgium

5. Biostatistics, Merck & Co., Inc. Kenilworth NJ USA

6. Synexus Helderberg Clinical Research Centre Somerset West South Africa

7. Mediclinic Panorama and Department of Obstetrics & GynaecologyUniversity of Stellenbosch Cape Town South Africa

8. Center for Clinical and Basic Research (CCBR) Tallinn Estonia

9. Centro Paulista de Investigações Clínicas São Paulo Brazil

10. Clinical Operations, Merck & Co., Inc. Kenilworth NJ USA

11. Clinical, Merck & Co., Inc. Kenilworth NJ USA